Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO in Neonatal HIE
NCT00808704Phase 2Completed
- Sponsor
- Zhengzhou University
- Start
- Aug 2003
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in hypoxic-ischemic encephalopathy (HIE), sponsored by Zhengzhou University. Started Aug 2003; status: completed.
02
Drugs
erythropoietin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT00808704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808704.